Significance and utility of plasma brain natriuretic peptide concentrations in patients with idiopathic ventricular arrhythmias

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 12, 2006, Pages 1395-1403

  Tada, Hiroshi ^a   Ito, Sachiko ^a   Shinbo, Goro ^a   Tadokoro, Kazuyoshi ^a   Ito, Itaru ^a   Hashimoto, Tohru ^a   Miyaji, Kohei ^a   Kaseno, Kenichi ^a   Naito, Shigeto ^a   Nogami, Akihiko ^b   Oshima, Shigeru ^a   Taniguchi, Koichi ^a  

^a GUNMA PREFECTURAL CARDIOVASCULAR CENTER   (Japan)

^b YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Ablation; B type natriuretic peptide; Idiopathic; Ventricular arrhythmia

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CATHETER ABLATION; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33845621072     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00553.x     Document Type: Article

References (29)

1. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC Jr, Francis GS, Mehra MR, et al., BNP Consensus Panel. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004; 10(5 Suppl 3):1-30.
2. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review. Clin Chem 2004; 50:33-50.
3. Vanderheyden M, Goethals M, Verstreken S, De Bruyne B, Muller K, Van Schuerbeeck E, Bartunek J. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004; 44:2349-2354.
4. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105:595-601.
5. McKie PM, Burnett JC Jr.. B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Mayo Clin Proc 2005; 80:1029-1036.
6. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663.
7. Sutovsky I, Katoh T, Ohno T, Honma H, Takayama H, Takano T. Relationship between brain natriuretic peptide, myocardial wall stress, and ventricular arrhythmia severity. Jpn Heart J 2004; 45:771-777.
8. Sekiguchi Y, Aonuma K, Yamauchi Y, Obayashi T, Niwa A, Hachiya H, Takahashi A, et al. Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats. J Cardiovasc Electrophysiol 2005; 16:1057-1063.
9. Watanabe MA, Marine JE, Sheldon R, Josephson ME. Effects of ventricular premature stimulus coupling interval on blood pressure and heart rate turbulence. Circulation 2002; 106:325-330.
10. Davies LC, Francis DP, Ponikowski P, Piepoli MF, Coats AJ. Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol 2001; 87:737-742.
11. Daoud E, Morady F. Catheter ablation of ventricular tachycardia. Curr Opin Cardiol 1995; 10:21-25.
12. Coggins DL, Lee RJ, Sweeney J, Chein WW, Van Hare G, Epstein L, Gonzalez R, et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994; 23:1333-1341.
13. Ito S, Tada H, Naito S, Kurosaki K, Ueda M, Hoshizaki H, Miyamori I, et al. Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol 2003; 14:1280-1286.
14. Tada H, Ito S, Naito S, Kurosaki K, Kubota S, Sugiyasu A, Tsuchiya T, et al. Idiopathic ventricular arrhythmia arising from the mitral annulus: A distinct subgroup of idiopathic ventricular arrhythmias. J Am Coll Cardiol 2005; 45:877-886.
15. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28:22-30.
16. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, et al. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26:771-782.
17. Celis H, Den Hond E, Staessen JA. Self-Measurement of blood pressure at home in the management of hypertension. Clin Med Res 2005; 3:19-26.
18. Tsuji T, Imagawa K, Masuda H, Haraikawa M, Shibata K, Kono M, Inouye K, et al. Stabilization of human natriuretic peptide in blood samples. Clin Chem 1994; 40:672-673.
19. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4:1222-1230.
20. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37:7-11.
21. Liang F, Gardner DG. Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism. J Clin Invest 1999; 104:1603-1612.
22. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, Fuchtbauer EM, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: Influence of angiotensin II and diastolic fiber length. Circulation 2000; 102:3074-3079.
23. Villari B, Vassalli G, Schneider J, Chiariello M, Hess OM. Age dependency of left ventricular diastolic function in pressure overload hypertrophy. J Am Coll Cardiol 1997; 29:181-186.
24. Isoyama S, Wei JY, Izumo S, Fort P, Schoen FJ, Grossman W. Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res 1987; 61:337-345.
25. Anversa P, Hiler B, Ricci R, Guideri G, Olivetti G. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol 1986; 8:1441-1448.
26. Lakatta EG, Mitchell JH, Pomerance A, Rowe GG. Human aging: Changes in structure and function. J Am Coll Cardiol 1987; 10(2 Suppl A):42A-47A.
27. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28:988-994.
28. Michelson EL, Morganroth J. Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording. Circulation 1980; 61:690-695.
29. Wu AH, Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. Eur J Heart Fail 2004; 6:355-358.